Cosmo Bio Company,Limited (TYO:3386)
Japan · Delayed Price · Currency is JPY 1,233.00
0.00 (0.00%)
Aug 19, 2026, 1:09 PM JST
Cosmo Bio Company,Limited Market Cap
Cosmo Bio Company,Limited has a market cap or net worth of 7.03 billion as of August 18, 2026. Its market cap has increased by 4.94% in one year.
Market Cap
7.03B
Enterprise Value
3.57B
Revenue
11.28B
Ranking
n/a
PE Ratio
19.23
Stock Price
1,233.00
ChartMarket Cap Chart
Since September 27, 2005, Cosmo Bio Company,Limited's market cap has decreased from 11.66B to 7.03B, a decrease of -39.76%. That is a compound annual growth rate of -2.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 7.03B | -5.06% |
| Dec 30, 2025 | 7.40B | 18.67% |
| Dec 30, 2024 | 6.24B | 8.71% |
| Dec 29, 2023 | 5.74B | -2.42% |
| Dec 30, 2022 | 5.88B | -12.66% |
| Dec 30, 2021 | 6.73B | -7.40% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 11.41T |
| Takeda Pharmaceutical Company | 8.96T |
| HOYA Corporation | 8.91T |
| Otsuka Holdings | 6.32T |
| BrightPath Biotherapeutics | 7.22B |
| Tsubota Laboratory | 7.15B |
| ADR Biomedical Holdings | 7.05B |
| UCHIYAMA HOLDINGS | 7.04B |